Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Curran

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Journal for Immunotherapy of Cancer|November 28, 2019
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanomaMatthew J Reilley, Brittany Morrow, Casey R Ager, et al.
Cancer Immunology Research|July 5, 2017
Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor ImmunityCasey R Ager, Matthew J Reilley, Courtney Nicholas, et al.
Biochemical and Biophysical Research Communications|July 9, 2004
Prolonged liver-specific transgene expression by a non-primate lentiviral vectorReba Condiotti, Michael A Curran, Garry P Nolan, et al.
Cancer Discovery|April 3, 2021
Development of Immunotherapy Combination Strategies in CancerTimothy A Yap, Eileen E Parkes, Weiyi Peng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2005
Prolonged transgene expression in murine salivary glands following non-primate lentiviral vector transductionEla Shai, Aaron Palmon, Amos Panet, et al.
Cancer Research Communications|May 16, 2025
NLRP3 Inflammasome Activation Expands the Immunosuppressive Myeloid Stroma and Antagonizes the Therapeutic Benefit of STING Activation in GlioblastomaSpencer T Lea, Chao-Hsien Chen, Jun Wei, et al.
Plos One|April 12, 2012
Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancerRobert R Jenq, Michael A Curran, Gabrielle L Goldberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2015
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccineTodd Bartkowiak, Shailbala Singh, Guojun Yang, et al.
JCI Insight|November 21, 2023
Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltrationArthur Liu, Seth T Gammon, Federica Pisaneschi, et al.
Journal of Hepatocellular Carcinoma|October 1, 2021
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular CarcinomaBetul Gok Yavuz, Elshad Hasanov, Sunyoung S Lee, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Journal for Immunotherapy of Cancer|November 28, 2019
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanomaMatthew J Reilley, Brittany Morrow, Casey R Ager, et al.
Cancer Immunology Research|July 5, 2017
Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor ImmunityCasey R Ager, Matthew J Reilley, Courtney Nicholas, et al.
Biochemical and Biophysical Research Communications|July 9, 2004
Prolonged liver-specific transgene expression by a non-primate lentiviral vectorReba Condiotti, Michael A Curran, Garry P Nolan, et al.
Cancer Discovery|April 3, 2021
Development of Immunotherapy Combination Strategies in CancerTimothy A Yap, Eileen E Parkes, Weiyi Peng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 21, 2005
Prolonged transgene expression in murine salivary glands following non-primate lentiviral vector transductionEla Shai, Aaron Palmon, Amos Panet, et al.
Cancer Research Communications|May 16, 2025
NLRP3 Inflammasome Activation Expands the Immunosuppressive Myeloid Stroma and Antagonizes the Therapeutic Benefit of STING Activation in GlioblastomaSpencer T Lea, Chao-Hsien Chen, Jun Wei, et al.
Plos One|April 12, 2012
Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancerRobert R Jenq, Michael A Curran, Gabrielle L Goldberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2015
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccineTodd Bartkowiak, Shailbala Singh, Guojun Yang, et al.
JCI Insight|November 21, 2023
Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltrationArthur Liu, Seth T Gammon, Federica Pisaneschi, et al.
Journal of Hepatocellular Carcinoma|October 1, 2021
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular CarcinomaBetul Gok Yavuz, Elshad Hasanov, Sunyoung S Lee, et al.
Pageof 9